运动对儿童喘的影响:随机对照试验的系统审查和元分析
Zhenghui Zha1, Yuli Zhang2, Cuiyun Tian3
1School of Physical Education and Health, Zhaoqing University, Zhaoqing, 526000, Guangdong Province, China.
Current allergy and asthma reports
|September 19, 2025
概括
运动可以改善喘儿童的运动能力和生活质量,但不能减少呼吸道炎症. 短期运动 (不到8周) 可能暂时提高肺功能,但好处不会持续.
科学领域:
- 儿科肺病学 儿科肺病学
- 运动生理学 运动生理学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘是儿童普遍存在的呼吸系统疾病.
- 运动对儿童喘的影响需要进一步澄清.
研究的目的:
- 系统地评估运动对患有喘的儿童的影响.
- 评估对肺功能,运动能力,呼吸道炎症和生活质量的影响.
主要方法:
- 对13项随机对照试验 (RCT) 的元分析.
- 包括673名患有喘的儿童 (平均年龄为7.3-14岁).
主要成果:
- 运动改善了6分钟步行测试距离和儿科喘生活质量问卷分数.
- 没有观察到微分呼出氧化 (FeNO) 的显著减少.
- 短期 (≤8周) 运动改善了FVC%和FEF 25-75%,但没有FEV1%,没有持续的肺功能益处.
结论:
- 运动训练可以提高喘儿童的运动能力和与健康有关的生活质量.
- 运动似乎没有减少气道炎症.
- 从运动中改善肺功能是暂时的,特别是在8周以后.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K


